Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management

This publication has 182 references indexed in Scilit:

• Lamina Propria Lymphocytes, Not Macrophages, Express CCR5 and CXCR4 and Are the Likely Target Cell for Human Immunodeficiency Virus Type 1 in the Intestinal Mucosa
  The Journal of Infectious Diseases, 2000
• Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
  The Lancet, 1999
• Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy
  New England Journal of Medicine, 1999
• Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
  The Lancet, 1998
• Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease
  European Journal of Clinical Microbiology & Infectious Diseases, 1998
• Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
  The Lancet, 1998
• Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1
  The Lancet, 1997
• Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group.
  Gut, 1995
• Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection
  New England Journal of Medicine, 1991
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987